Introducing way more signals! We've added more signal sources to capture the full customer journey.

Learn More!
Carmat

Carmat

A credible response to end-stage heart failure: CARMAT aims to eventually provide a response to a major public health issue associated with heart disease, the world's leading cause of death: chronic and acute heart failure. By pursuing the development of its total artificial heart, CARMAT intends to overcome the well-known shortfall in heart transplants for the tens of thousands of people suffering from irreversible end-stage heart failure, the most seriously affected of the 20 million patients with this progressive disease in Europe and the United States. The result of combining two types of unique expertise: the medical expertise of Professor Carpentier, known throughout the world for inventing Carpentier-Edwards® heart valves, which are the most used in the world, and the technological expertise of Airbus Group, world aerospace leader. Imitating the natural heart: given its size, the choice of structural materials and its innovative physiological functions, CARMAT's total artificial heart could, assuming the necessary clinical trials are successful, potentially benefit the lives of thousands of patients a year with no risk of rejection and with a good quality of life. A project leader acknowledged at a European level: with the backing of the European Commission, CARMAT has been granted the largest subsidy ever given to an SME by Bpifrance; a total of €33 million. Strongly committed, prestigious founders and shareholders: Airbus Group (Matra Défense), Professor Alain Carpentier, the Centre Chirurgical Marie Lannelongue, Truffle Capital, a leading European venture capital firm, ALIAD, Air Liquide's venture capital investor, CorNovum, an investment holding company held 50-50 by Bpifrance and the French State, the family offices of Pierre Bastid (ZAKA) and of Dr. Antonino Ligresti (Santé Holdings S.R.L.) as well as the thousands of institutional and individual shareholders who have placed their trust in CARMAT.

Last updated on

About Carmat

Founded

2008

Estimated Revenue

$1M-$10M

Employees

51-250

Funding / Mkt. Cap

$247M

Category

Industry Group

Surgical, Medical, and Dental Instruments and Supplies

Industry

Medical Devices

Location

City

Velizy-Villacoublay

State

Ile-de-France

Country

France
Carmat

Carmat

Find your buyer within Carmat

Tech Stack (34)

search

Programming Languages And Frameworks

Marketing

Devops And Development

Customer Management

Collaboration

Platform And Storage

Product And Design

Business Intelligence And Analytics

Payment

Audio / Video Media

Content Management System

JavaScript Libraries and Functions

Web Hosting Providers

Web Servers